The ABPI and the Pharmaceutical Marketing (PM) Society have formally agreed to work together in promoting and advancing the UK pharmaceutical industry.

The two organisations have signed a memorandum of understanding (MoU) committing them to align activities that are relevant to their shared interests.

Areas of joint working suggested by the MoU include training, events and member surveys to identify issues and facilitate planning in the industry.

The PM Society promotes marketing excellence in the healthcare industry. Run by volunteers as a non-profit organisation, it has members in 230 UK companies.

In 2012 the PM Society introduced a number of Interest Groups focused on current challenges: market access, digital marketing, NHS partnerships, patient engagement and personal development.

The ABPI represents research-based biopharmaceutical companies in the UK, and is recognised by the Government as the body negotiating on behalf of the branded pharmaceutical industry.

“The PM Society reaches out to the operational heart of the UK pharmaceutical and life sciences industries and is a natural partner to promote debate and discussion with the people we serve,” said ABPI Chief Executive Stephen Whitehead.

“The working groups in market access, NHS partnerships and patient engagement, aligned as they are with many of our strategic imperatives, offer particular potential for joint working.”

Neil Copping (pictured), Chairman of the PM Society, commented: “Since we redefined the Society early last year, we have looked to address members’ needs more effectively in the rapidly changing healthcare environment.

“Aligning strategic and grass roots level activities by joining forces with the ABPI, we aim to open new doors and deliver increased value and benefit to both organisations’ membership.

“It will also avoid duplication on initiatives that are relevant industry-wide and might otherwise have been under discussion by both organisations.”

The meetings and events sector is today recognised as a core revenue stream for academic venues. Sam Booth explains how schools, colleges and universities can give your meeting a degree of excellence.

The majority of academic venues offering conference facilities now function under a dedicated brand with a specialist conference team and, despite operating in a difficult economic environment, the majority have continued to invest in the upkeep and improvement of their facilities. It is because of this that the academic venue provides some of the highest quality conference and events facilities available for event organisers today.

With such large scale purpose built facilities it is not surprising that the academic venue has become the preference for many organisations’ annual conferences and conventions. Combined with state-of-the art audio and visual support, a mix of old and new facilities, and a vast amount of high quality on-site accommodation, they provide a one-stop shop approach to modern conferencing.

Extracurricular facilities

With the addition of some of the more unique sections of the university being opened up for use, they have also become a popular choice for product launches, awards dinners and even large exhibitions. Sports facilities are also another great asset, playing host to tournaments or team building for many different groups.

It is because of the fact that all of these facilities are already in place that the academic venue can offer a competitive price for delegates, unlike many purpose built conference centres or hotels.

However, it is not just the top class facilities or cost effective offering that is attracting event organisers. The sheer amount of supporting research and access to academic speakers at a university is also playing a major influencing factor on choice. Coupled with the fact that the facilities have been built with learning in mind, this element can enhance and enrich an event and in turn help to add credibility and increase delegate engagement too.

School fees

In return, students and academics will benefit from this too with all profits generated being reinvested directly back into the university, giving research programmes and other learning facilities a welcome boost in resources.

The academic venue is a vibrant, unique and highly cultured choice for any event and can help make a significant contribution in paving the way for the country’s next generation of leaders. I would urge anyone to give them a try.

Sam Booth is the Head of Keele Conferences and Events.

European medtech industry association Eucomed will launch a conference pre-vetting system in early 2012 to assess all third-party educational conferences and congresses sponsored by its members.

The new system is the first of its kind in the healthcare industry, because its assessments will be binding.

The independent Eucomed Compliance Panel will assess educational events for compliance with the association’s Code of Ethical Business Practice in relation to such factors as scientific content, location and venue.

Each outcome will be made publicly available via a dedicated website, and relevant stakeholders will be notified.

The Eucomed Code allows member companies to sponsor third-party educational events such as medical congresses, seminars and training courses, subject to restrictions. Until now, members had to establish their compliance independently. The new system will apply a uniform compliance determination process to all Eucomed members.

“The conference pre-vetting system is a unique initiative in the healthcare sector,” said John McLoughlin, Chairman of the Compliance Panel. “It will be supervised solely by our Panel, which is a completely independent body. Eucomed members are required to follow the assessments.

“If a conference receives a negative assessment, Eucomed members may not sponsor either the conference or individual healthcare professionals who wish to attend the conference.”

John Wilkinson, Eucomed’s Chief Executive, added that the new system “is not only necessary for our members in their day-to-day activities but is also key to increasing the consistency and transparency of industry behaviour.”

Eucomed intends to give key stakeholders an opportunity to comment on the assessment criteria.

The pre-vetting system will begin as a pilot and be reviewed 6–12 months after its launch. It will be the sole responsibility of the Compliance Panel.

Eucomed represents 22,500 designers, manufacturers and suppliers of medical technologies in Europe.